We are live on
!
Find out more
SCM
SOL Capital Management Portfolio holdings
AUM
$206M
Turnover
90.91%
1-Year Est. Return
17.87%
This Fund
S&P 500
This Quarter
Est. Return
+5.18%
1 Year Est. Return
+17.87%
3 Year Est. Return
+56.62%
5 Year Est. Return
+56.1%
10 Year Est. Return
+238.92%
AUM
$354M
AUM Growth
-$9.29M
(-2.6%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-6.89%
Top 10 Holdings %
Top 10 Hldgs %
25.66%
Holding
255
New
9
Increased
72
Reduced
112
Closed
9
Avg Time Held
3.1
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.27M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$673K |
| 3 |
DuPont de Nemours
DD
|
+$416K |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$381K |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$307K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$12.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.42M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.31M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.15M |
| 5 |
iShares Short Maturity Bond ETF
NEAR
|
+$955K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.15% |
| 2 | Financials | 15% |
| 3 | Technology | 7.36% |
| 4 | Healthcare | 5.53% |
| 5 | Consumer Discretionary | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.5B
| $417K | 0.12% |
35,667
-2,400
| -6% | -$27.3K |
2014 Q3
12 quarters
|
|
177
General Motors
GM
$73.4B
| $416K | 0.12% |
10,300
+200
| +2% | +$7.31K |
2016 Q4
3 quarters
|
|
178
iShares MSCI EAFE ETF
EFA
$76.9B
| $411K | 0.12% |
6,000
-12,300
| -67% | -$822K |
2016 Q4
3 quarters
|
|
179
DELISTED
Chesapeake Energy Corporation
CHK
| $409K | 0.12% |
475
+115
| +32% | +$98.7K |
2013 Q2
17 quarters
|
|
180
Medtronic
MDT
$122B
| $405K | 0.11% |
5,205
-143
| -3% | -$11.9K |
2015 Q1
10 quarters
|
|
181
Invesco Water Resources ETF
PHO
$1.95B
| $405K | 0.11% |
14,200
| – | – |
2013 Q2
17 quarters
|
|
182
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $405K | 0.11% |
8,996
| – | – |
2016 Q2
5 quarters
|
|
183
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $401K | 0.11% |
1,230
+140
| +13% | +$44.5K |
2015 Q1
10 quarters
|
|
184
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $401K | 0.11% |
2,630
-120
| -4% | -$17.6K |
2016 Q3
4 quarters
|
|
185
SLB Ltd
SLB
$71.8B
| $399K | 0.11% |
5,726
+500
| +10% | +$33.1K |
2013 Q2
17 quarters
|
|
186
State Street SPDR S&P Metals & Mining ETF
XME
$4.02B
| $398K | 0.11% |
12,375
-2,000
| -14% | -$62.7K |
2014 Q4
11 quarters
|
|
187
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.53B
| $395K | 0.11% |
5,170
+1,660
| +47% | +$123K |
2017 Q1
2 quarters
|
|
188
Merck
MRK
$358B
| $388K | 0.11% |
6,350
-105
| -2% | -$6.37K |
2013 Q2
17 quarters
|
|
189
GSK
GSK
$98.2B
| $381K | 0.11% |
7,514
+240
| +3% | +$12.2K |
2013 Q2
17 quarters
|
|
190
iShares Core S&P US Value ETF
IUSV
$27.9B
| $370K | 0.1% |
7,060
| – | – |
2017 Q1
2 quarters
|
|
191
iShares S&P 500 Value ETF
IVE
$49.9B
| $369K | 0.1% |
3,420
+475
| +16% | +$50.3K |
2017 Q2
1 quarter
|
|
192
Avis
CAR
$3.88B
| $363K | 0.1% |
9,540
| – | – |
2013 Q2
17 quarters
|
|
193
HSBC
HSBC
$323B
| $360K | 0.1% |
7,980
-111
| -1% | -$4.91K |
2016 Q2
5 quarters
|
|
194
Agilent Technologies
A
$49.5B
| $357K | 0.1% |
5,561
-25
| -0.4% | -$1.56K |
2015 Q4
7 quarters
|
|
195
Visa
V
$750B
| $344K | 0.1% |
3,273
-700
| -18% | -$71K |
2013 Q2
17 quarters
|
|
196
Blackstone Mortgage Trust
BXMT
$1.82B
| $329K | 0.09% |
10,600
+2,200
| +26% | +$68.4K |
2017 Q1
2 quarters
|
|
197
iShares Core S&P 500 ETF
IVV
$889B
| $328K | 0.09% |
1,297
-1,190
| -48% | -$296K |
2017 Q1
2 quarters
|
|
198
Morgan Stanley
MS
$286B
| $328K | 0.09% |
6,800
-340
| -5% | -$15.8K |
2016 Q3
4 quarters
|
|
199
Honda
HMC
$44.2B
| $321K | 0.09% |
10,868
-100
| -0.9% | -$2.82K |
2013 Q2
17 quarters
|
|
200
Newmont
NEM
$122B
| $319K | 0.09% |
8,500
-400
| -4% | -$14.5K |
2013 Q2
17 quarters
|
|
Similar funds
BOJHT
TC
CC
MFG
SPI
GL
TVM
LLWM
SOL Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, SOL Capital Management held 255 positions worth $354M, down 2.6% from $364M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
SOL Capital Management withdrew a net $24.4M in Q3 2017, closing 9 positions and reducing 112 holdings. Its most notable exit was Vanguard Short-Term Corporate Bond ETF, an estimated $1.31M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 56% a quarter earlier, followed by Financials and Technology.
Against the trend, SOL Capital Management opened a new position in DuPont de Nemours worth $437K.
- SOL Capital Management's largest Q3 2017 buy was DuPont de Nemours: 2,492 shares worth $437K.
- SOL Capital Management added most to Teva Pharmaceutical Industries Limited in Q3 2017, an estimated $1.27M increase.
- SOL Capital Management's biggest Q3 2017 reduction was Tapestry, cutting an estimated $12.5M.
- SOL Capital Management fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2017, selling an estimated $1.31M.
- SOL Capital Management's ten largest holdings make up 26% of its $354M portfolio in Q3 2017.
- SOL Capital Management opened 9 new positions and closed 9 in Q3 2017.
- SOL Capital Management's portfolio value fell 2.6% quarter-over-quarter to $354M.
Based on SOL Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.